Candesartan Causes Long-lasting Antagonism of the Angiotensin II Receptor-mediated Contractile Effects in Isolated Vascular Preparations: a Comparison with Irbesartan, Losartan and its Active Metabolite (EXP-3174)

By ABRAHAMSSON T.   KARP L.   BRANDT-ELIASSON U.   MORSING P.   RENBERG L.   SJÖQUIST P.-O.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 52-52

Informa Healthcare

Access to resources Recommend Favorite

The Antihypertensive Effect and Tolerability of Candesartan Cilexetil, a New Generation Angiotensin II Antagonist, in Comparison with Losartan

By ANDERSSON OVE K.   NELDAM STEEN  

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 53-59

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the Angiotensin II Receptor Antagonist Irbesartan With Atenolol for Treatment of Hypertension

By STUMPE K. O.   HAWORTH D.   HÖGLUND C.   KERWIN L.   MARTIN A.   SIMON T.   MASSON C.   KASSLER-TAUB K.   OSBAKKEN M.  

Blood Pressure, Vol. 7, Iss. 1, 1998-04 ,pp. : 31-37

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II-mediated Growth and Antigrowth Effects in Cultured Neonatal Rat Cardiac Myocytes and Fibroblasts

By van Kesteren C.A.M.   van Heugten H.A.A.   Lamers J.M.J.   Saxena P.R.   Schalekamp M.A.D.H.   Danser A.H.J.  

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 8, 1997-08 ,pp. : 2147-2157

Academic Press

Access to resources Recommend Favorite

Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability

By ELMFELDT D.   GEORGE M.   HÜBNER R.   OLOFSSON B.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 54-54

Informa Healthcare

Access to resources Recommend Favorite